Zobrazit minimální záznam

dc.contributor.authorCharousová, Markéta
dc.contributor.authorKudlickova Peskova, Marie
dc.contributor.authorTakácsová, Paulína
dc.contributor.authorKapołková, Kateřina
dc.contributor.authorHaddad, Yazan Abdulmajeed Eyadh
dc.contributor.authorBílek, Jan
dc.contributor.authorSivák, Ladislav
dc.contributor.authorBartejs, Tomas
dc.contributor.authorHeger, Zbyněk
dc.contributor.authorPekařík, Vladimír
dc.date.accessioned2025-01-29T01:03:20Z
dc.date.available2025-01-29T01:03:20Z
dc.date.issued2024
dc.identifier.issn2047-4830 Sherpa/RoMEO, JCR
dc.identifier.urihttps://repozitar.mendelu.cz/xmlui/handle/20.500.12698/2014
dc.description.abstractFerritins are globular proteins with an internal cavity that enables the encapsulation of a plethora of low-mass compounds. Unfortunately, the overall negative surface charge of ferritin's internal cavity hampers efficient loading of negatively charged molecules. Therefore, we produced a genetically engineered human H-chain ferritin containing a cationic RKRK domain, reversing the natural net charge of the cavity to positive, thus allowing for efficient encapsulation of negatively charged siRNA. Due to the reversed, positive charge mediated by RKRK domains, the recombinant ferritin produced in E. coli inherently carries a load of bacterial RNA inside its cavity, turning the protein into an effective sponge possessing high affinity for DNA/RNA-binding substances that can be loaded with markedly higher efficiency compared to the wildtype protein. Using doxorubicin as payload, we show that due to its loading through the RNA sponge, doxorubicin is released in a sustained manner, with a cytotoxicity profile similar to the free drug. In summary, this is the first report demonstrating a ferritin/nucleic acid hybrid delivery vehicle with a broad spectrum of properties exploitable in various fields of biomedical applications.en
dc.format1249-1262
dc.publisherRoyal Society of Chemistry
dc.relation.ispartofBiomaterials Science
dc.relation.urihttps://doi.org/10.1039/d3bm01257c
dc.rightsCC BY 3.0
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/
dc.subjectdelivery-systemen
dc.subjectnanoparticlesen
dc.subjectapoferritinen
dc.subjectencapsulationen
dc.subjectdoxorubicinen
dc.subjectsolubilityen
dc.subjectnanocageen
dc.subjectsirnaen
dc.subjectnanoclustersen
dc.subjectdegradationen
dc.titleEngineered human H-chain ferritin with reversed charge of the internal cavity exhibits RNA-mediated spongelike effect for loading RNA/DNA-binding moleculesen
dc.typeJ_ČLÁNEK
dc.date.updated2025-01-29T01:03:19Z
dc.description.versionOA-hybrid
local.identifier.doi10.1039/d3bm01257c
local.identifier.scopus2-s2.0-85182924190
local.identifier.wos001147894000001
local.number5
local.volume12
local.identifier.obd43926190
local.identifier.e-issn2047-4849
dc.project.IDAF-IGA2022-IP-018
dc.project.IDNU20-03-00477
dc.project.IDGA22-14568S
dc.project.IDZvýšení stability ferritinových nanotransportérů a odstranění aktivních látek z jejich povrchu
dc.project.IDSmart biokompatabilní nanonástroje pro selektivní doručení drug-siRNA koktejlů pro kombinovanou terapii rakoviny prsu
dc.project.IDBiodistribuce a real-time monitoring volných nebo apoferitinem enkapsulovaných kvarterních reaktivátorů cholinesteras
dc.identifier.orcidCharousová, Markéta 0000-0001-9027-4002
dc.identifier.orcidTakácsová, Paulína 0000-0003-1978-0070
dc.identifier.orcidHaddad, Yazan Abdulmajeed Eyadh 0000-0002-7844-4336
dc.identifier.orcidSivák, Ladislav 0000-0003-2623-8458
dc.identifier.orcidHeger, Zbyněk 0000-0002-3915-7270
dc.identifier.orcidPekařík, Vladimír 0000-0001-6362-9007
local.contributor.affiliationAF


Soubory tohoto záznamu

Thumbnail

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam

CC BY 3.0
Kromě případů, kde je uvedeno jinak, licence tohoto záznamu je CC BY 3.0